They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| A M R CP | AAMRQ | 10.54% |
| P L C SYSTEM | PLCSF | 9.19% |
| HUTCHINSON T | HTCH | 6.31% |
| USANA HEALTH | USNA | 6.20% |
| KRATOS DEFEN | KTOS | 5.65% |
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest. Today, you can see them free.
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
First quarter earnings season is well underway, and in terms of earnings beats, things look fine. According to Zacks Director of Research Sheraz Mian in his daily Ahead of Wall Street piece, about two-third of companies have reported positive earnings surprises this quarter, which is in-line with a typical healthy earnings season.
However, things are not so favorable when it comes to revenues. Only about one-in-three companies have beaten revenue expectations, which is well below normal. Perhaps more troubling, overall revenues are down -0.7% year-over-year in Q1.
Certainly some of this weakness can be attributed to a strong U.S. dollar, since a little less than half of all revenue on the S&P 500 comes from overseas. But global economic weakness is also to blame.
It's also worth noting that companies have been known to massage their EPS numbers to beat the Street, but revenue is more difficult for management to manipulate (just sayin').
So how concerned are you about weak revenues this quarter? And what implications do you think this has for earnings in future quarters?
Chime in below.
Read the full reports :
ETF report on SPY
ETF report on DIA
ETF report on QQQ
ETF report on IWM
ETF report on MDY